← Back to Search

Mobile Health App for Cancer Advance Care Planning

N/A

Waitlist Available

Led By Megan J Shen, PhD

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older.

Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic cancer (e.g., pancreaticobiliary, esophagogastric, hepatocellular carcinoma, lung, or gynecological cancer) and/or disease progression following at least first line chemotherapy.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 months

Awards & highlights

Study Summary

This trial tests a new app called PACT to help people with cancer talk to loved ones and doctors about the care they would want if they were unable to communicate. The app may help patients include their social network in future advance care planning.

Who is the study for?

This trial is for adults over 18 with advanced cancers like pancreatic, liver, lung, or gynecological cancer who've had at least one round of chemotherapy. Participants need internet access on a mobile device and an English-speaking loved one to join the study. It's not for those under 18, in hospice care, severely cognitively impaired, non-English speakers, or too ill to do interviews.Check my eligibility

What is being tested?

The trial is testing the PACT mobile app designed to facilitate advance care planning discussions among cancer patients with their families and doctors. The aim is to integrate social support into making future healthcare decisions if they can't communicate themselves.See study design

What are the potential side effects?

Since this intervention involves using a mobile health application and questionnaires rather than medication or medical procedures, traditional physical side effects are not expected. However, emotional distress from discussing sensitive end-of-life plans may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My advanced cancer has worsened after the first treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the PACT application: Acceptability E-Scale [Patients]

Acceptability of the PACT application: Acceptability E-Scale [Support persons]

Change in completion of advance directives

+16 more

Secondary outcome measures

Change in family functioning

Change in healthcare utilization (summary score for total number of healthcare services utilized)

Change in number of subjects receiving goal-concordant care

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (PACT)Experimental Treatment2 Interventions

Participants use PACT mHealth app.

Group II: Arm II (standard care)Active Control2 Interventions

Participants engage in standard care with no modifications.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor

1,054 Previous Clinical Trials

1,316,128 Total Patients Enrolled

Fred Hutchinson Cancer CenterLead Sponsor

556 Previous Clinical Trials

1,342,868 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,932,753 Total Patients Enrolled

Media Library

PACT Clinical Trial Eligibility Overview. Trial Name: NCT04515810 — N/A

Cancer Research Study Groups: Arm I (PACT), Arm II (standard care)

Cancer Clinical Trial 2023: PACT Highlights & Side Effects. Trial Name: NCT04515810 — N/A

PACT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04515810 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are included in the scope of this medical experiment?

"Affirmative. Clinicaltrials.gov hosts data indicating that this clinical trial is presently accepting participants, having been originally posted on November 21st 2022 and most recently updated October 21st 2022. 490 patients across 7 locations are being recruited for the study."

Answered by AI

What is the primary aim of this investigation?

"This experiment will be closely monitored across Baseline, 3 months post-intervention, and 6 months post-intervention. The primary end goal is to track any alterations in advance care planning conversations. Additionally, the team plans on assessing changes in treatment preference (by utilizing a two answer choice question), perceived social support (using the MSPSS which has five points of response from strongly disagree to strongly agree) and family functioning (utilizing FRI with scores ranging from one to four)."

Answered by AI

Is recruitment for this research effort open to the public?

"Affirmative. The clinicaltrial.gov website confirms that this medical research is still open to participant applications, having been first posted on November 21st 2022 and recently updated on October 21st 2022. A total of 490 patients are needed from 7 different sites for the study's completion."

Answered by AI

Recent research and studies

Journal of Personality AssessmentJournal

Psychometric Characteristics of the Multidimensional Scale of Perceived Social Support

Zimet, Gregory D., Suzanne S. Powell, Gordon K. Farley, Sidney Werkman, and Karen A. Berkoff. 1990. “Psychometric Characteristics of the Multidimensional Scale of Perceived Social Support”. Journal of Personality Assessment. Informa UK Limited. doi:10.1080/00223891.1990.9674095.

Journal of the American Medical Directors AssociationJournal

Efficacy of Advance Care Planning: A Systematic Review and Meta-analysis

Houben, Carmen H.M., Martijn A. Spruit, Miriam T.J. Groenen, Emiel F.M. Wouters, and Daisy J.A. Janssen. 2014. “Efficacy of Advance Care Planning: A Systematic Review and Meta-analysis”. Journal of the American Medical Directors Association. Elsevier BV. doi:10.1016/j.jamda.2014.01.008.

Multivariate Behavioral ResearchJournal

Addressing Moderated Mediation Hypotheses: Theory, Methods, and Prescriptions

Preacher, Kristopher J., Derek D. Rucker, and Andrew F. Hayes. 2007. “Addressing Moderated Mediation Hypotheses: Theory, Methods, and Prescriptions”. Multivariate Behavioral Research. Informa UK Limited. doi:10.1080/00273170701341316.

Cognitive ProcessingJournal